FDA drug class
Rifamycin Antimycobacterials list
Every FDA-approved prescription drug the FDA NDC directory tags with the Rifamycin Antimycobacterial [EPC] class, with brand names and DEA schedules.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
The FDA NDC directory lists 2 single-ingredient drugs in this class: rifabutin, rifapentine. Another 1 combination product include one of them.
Run it in Rivvi
Map your top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Rifamycin Antimycobacterials (3)
| Drug | Brand names | Type | NDC listings | DEA schedule |
|---|---|---|---|---|
| Rifabutin | None listed | Single ingredient | 6 | Not controlled |
| Rifapentine | Priftin | Single ingredient | 2 | Not controlled |
| Omeprazole, amoxicillin and rifabutin | Talicia | Combination | 1 | Not controlled |
FDA established pharmacologic class: Rifamycin Antimycobacterial [EPC].
Questions
What drugs are Rifamycin Antimycobacterials?
The FDA NDC directory lists 2 single-ingredient drugs in this class: rifabutin, rifapentine. Another 1 combination product include one of them.
Where does this list come from?
From the established pharmacologic class (EPC) field FDA publishes for each listing in the NDC directory. A drug is listed when most of its prescription listings carry the class.